International Stem Cell Corporation

OTCPK:ISCO Voorraadrapport

Marktkapitalisatie: US$480.3k

International Stem Cell Beheer

Beheer criteriumcontroles 4/4

International Stem Cell's CEO is Andrey Semechkin, appointed in Nov 2009, has a tenure of 15.92 years. total yearly compensation is $112.87K, comprised of 59% salary and 41% bonuses, including company stock and options. directly owns 53.3% of the company’s shares, worth $255.98K. The average tenure of the management team and the board of directors is 11.4 years and 16.1 years respectively.

Belangrijke informatie

Andrey Semechkin

Algemeen directeur

US$112.9k

Totale compensatie

Percentage CEO-salaris59.0%
Dienstverband CEO15yrs
Eigendom CEO53.3%
Management gemiddelde ambtstermijn11.4yrs
Gemiddelde ambtstermijn bestuur16.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Andrey Semechkin's beloning veranderd ten opzichte van International Stem Cell's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$467k

Mar 31 2024n/an/a

-US$311k

Dec 31 2023US$113kUS$67k

-US$131k

Sep 30 2023n/an/a

US$195k

Jun 30 2023n/an/a

-US$79k

Mar 31 2023n/an/a

-US$356k

Dec 31 2022US$396kUS$63k

-US$331k

Sep 30 2022n/an/a

-US$705k

Jun 30 2022n/an/a

-US$527k

Mar 31 2022n/an/a

-US$309k

Dec 31 2021US$126kUS$58k

-US$899k

Sep 30 2021n/an/a

-US$1m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$54kUS$54k

-US$3m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$201kUS$44k

-US$4m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$420kUS$48k

-US$2m

Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$4m

Dec 31 2017US$243kUS$102k

-US$6m

Compensatie versus markt: Andrey's total compensation ($USD112.87K) is below average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Andrey's compensation has been consistent with company performance over the past year.

CEO

Andrey Semechkin (64 yo)

15yrs

Tenure

US$112,865

Compensatie

Prof. Dr. Andrey Semechkin, Ph D., has been the Chief Executive Officer of International Stem Cell Corporation since November 15, 2009 and has been its Co-Chairman of the Board since October 6, 2011 and ha...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Andrey Semechkin
Co-Chairman of the Board & CEO15yrsUS$112.87k53.3%
$ 256.0k
Russell Kern
Executive VP11.4yrsUS$377.24k0%
$ 0
Rebecca McGee
President of Lifeline Cell Technology2.8yrsgeen gegevensgeen gegevens

11.4yrs

Gemiddelde duur

Ervaren management: ISCO's management team is seasoned and experienced (11.4 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Andrey Semechkin
Co-Chairman of the Board & CEO15.9yrsUS$112.87k53.3%
$ 256.0k
Russell Kern
Executive VP16.1yrsUS$377.24k0%
$ 0
Paul Maier
Independent Director17.3yrsUS$81.67k0.41%
$ 2.0k
Kenneth Aldrich
Co-Founder & Chairman Emeritus12.7yrsUS$1.32mgeen gegevens
Mark Hughes
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Donald Wright
Independent Co-Chairman of the Board17.7yrsUS$96.67k0.059%
$ 284.4
Evan Snyder
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Elena Revazova
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Hans-Dieter Volk
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Matthias von Herrath
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Michael Kalichman
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Rosario Sánchez-Pernaute
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens

16.1yrs

Gemiddelde duur

72yo

Gemiddelde leeftijd

Ervaren bestuur: ISCO's board of directors are seasoned and experienced ( 16.1 years average tenure).